DE69016129T2 - Vakzin gegen Escherichia coli. - Google Patents

Vakzin gegen Escherichia coli.

Info

Publication number
DE69016129T2
DE69016129T2 DE69016129T DE69016129T DE69016129T2 DE 69016129 T2 DE69016129 T2 DE 69016129T2 DE 69016129 T DE69016129 T DE 69016129T DE 69016129 T DE69016129 T DE 69016129T DE 69016129 T2 DE69016129 T2 DE 69016129T2
Authority
DE
Germany
Prior art keywords
toxin
coli
strains
vaccine
flagella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69016129T
Other languages
German (de)
English (en)
Other versions
DE69016129D1 (de
Inventor
Den Bosch Johannes Francis Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69016129D1 publication Critical patent/DE69016129D1/de
Application granted granted Critical
Publication of DE69016129T2 publication Critical patent/DE69016129T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69016129T 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli. Expired - Lifetime DE69016129T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
DE69016129D1 DE69016129D1 (de) 1995-03-02
DE69016129T2 true DE69016129T2 (de) 1995-05-24

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016129T Expired - Lifetime DE69016129T2 (de) 1989-08-18 1990-07-23 Vakzin gegen Escherichia coli.

Country Status (16)

Country Link
US (1) US5750115A (enExample)
EP (1) EP0413378B1 (enExample)
JP (1) JP3031561B2 (enExample)
KR (1) KR0177510B1 (enExample)
CN (1) CN1062605C (enExample)
AU (1) AU635062B2 (enExample)
CA (1) CA2022420C (enExample)
DE (1) DE69016129T2 (enExample)
DK (1) DK0413378T3 (enExample)
ES (1) ES2070266T3 (enExample)
GR (1) GR3015782T3 (enExample)
HU (2) HU210965B (enExample)
IL (1) IL95175A (enExample)
NZ (1) NZ234933A (enExample)
TW (1) TW204353B (enExample)
ZA (1) ZA906100B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
EP1076567A4 (en) * 1998-05-15 2001-12-12 Mkb Invest Ltd Partnership COMPOSITION AND METHOD FOR IMMUNIZATION OF POULTRY
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
BRPI0615593A2 (pt) 2005-08-30 2011-05-24 Commw Scient And Ind Reseaech Organisation liberação bacteriana de polipeptìdeos biologicamente ativos
WO2011046963A1 (en) 2009-10-12 2011-04-21 New Health Sciences, Inc. Oxygen depletion devices and methods for removing oxygen from red blood cells
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
CA2781866C (en) 2009-10-12 2019-12-03 New Health Sciences, Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
JP5930483B2 (ja) 2010-08-25 2016-06-08 ニュー・ヘルス・サイエンシーズ・インコーポレイテッドＮｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 保存中の赤血球の品質及び生存を高める方法
ES2793484T3 (es) 2010-11-05 2020-11-16 Hemanext Inc Irradiación de glóbulos rojos y almacenamiento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
ES2923571T3 (es) 2011-08-10 2022-09-28 Hemanext Inc Dispositivo integrado de filtrado de leucocitos, oxígeno y/o CO2 y separación de plasma
US9877476B2 (en) 2013-02-28 2018-01-30 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
MX2017011595A (es) 2015-03-10 2018-06-15 New Health Sciences Inc Kits, dispositivos descartables para reducir el oxígeno y métodos para usarlos.
AU2016253005B2 (en) 2015-04-23 2020-07-09 Hemanext Inc. Anaerobic blood storage containers
BR122021024421B1 (pt) 2015-05-18 2022-05-03 Hemanext Inc Usos de um produto de sangue total armazenado reduzido de oxigênio com plaquetas
WO2017205590A2 (en) 2016-05-27 2017-11-30 New Health Sciences, Inc. Anaerobic blood storage and pathogen inactivation method
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
DE3787820T2 (de) * 1986-03-11 1994-04-28 Shionogi & Co Für Flagellin kodierende DNS und dieses enthaltender Vektor.

Also Published As

Publication number Publication date
US5750115A (en) 1998-05-12
TW204353B (enExample) 1993-04-21
KR0177510B1 (ko) 1999-03-20
AU635062B2 (en) 1993-03-11
NZ234933A (en) 1992-06-25
CN1062605C (zh) 2001-02-28
ES2070266T3 (es) 1995-06-01
CA2022420C (en) 2000-03-28
GR3015782T3 (en) 1995-07-31
JPH03184996A (ja) 1991-08-12
EP0413378A1 (en) 1991-02-20
IL95175A0 (en) 1991-06-10
DE69016129D1 (de) 1995-03-02
AU6109990A (en) 1991-02-21
IL95175A (en) 1994-05-30
EP0413378B1 (en) 1995-01-18
HUT59612A (en) 1992-06-29
DK0413378T3 (da) 1995-05-15
HU211827A9 (en) 1995-12-28
ZA906100B (en) 1991-05-29
HU210965B (en) 1995-09-28
CN1049523A (zh) 1991-02-27
HU905053D0 (en) 1991-01-28
KR910004209A (ko) 1991-03-28
CA2022420A1 (en) 1991-02-19
JP3031561B2 (ja) 2000-04-10

Similar Documents

Publication Publication Date Title
KR0177510B1 (ko) 에스케리키아 콜리 백신
EP0633313B1 (de) Impfstoff gegen die Lyme-Krankheit
DE69423383T2 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
DE69012318T2 (de) Impfstoffe gegen hämophilus influenzae.
DE69231619T3 (de) Methode und Zusammensetzung zur Verhütung der Lyme-Krankheit
Verstreate et al. Outer membrane proteins of Brucella abortus: isolation and characterization
DE69032806T2 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
DE69333036T2 (de) DNA-Fragmente, die für die Untereinheiten von dem Neisseria Meningitidis Rezeptor kodieren
DE69333028T2 (de) Deletionsmutanten als impfstoffe gegen cholera
DE69110082T2 (de) Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
DE69635783T2 (de) Antigen omp26 aus haemophilus influenzae
DE69432658T2 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE69332243T2 (de) Hochmolekulare oberflächen-proteine des nicht-typisierbaren hämophilus
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE69110997T2 (de) Haemophilus Paragallinarum-Impfstoffe.
DE3856240T2 (de) Herstellung der p1 proteine und impfstoffe gegen gonorrhöe
DE69634003T2 (de) Hybrid-moleküle aus hitzelabilem enterotoxin und choleratoxin-b-untereinheiten
DE69226944T2 (de) Darstellung und verwendung von mit formalin abgetöteten e. coli bakterien, die das kolonie-faktor-antigen (cfa) expremieren zur impfung gegen das die darminfektion/diarrhoe in menschen auslösende darmbakterium e. coli
DE4116249A1 (de) Hybrid-plasmid fuer m.-tuberculosis-antigen, e. coli als wirt und antigen
DE69535422T2 (de) Vakzin für einen nicht typisierbaren Haemophilus influenzae Stamm
DE68926427T2 (de) Vom streptococcus m-protein abgeleitete synthetische peptide und damit hergestellte impfstoffe
DE68923286T2 (de) Impfstoffe und testsätze für haemophilus influenzae.
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
DE69835522T2 (de) Das 74 kilodalton protein der äusseren membran von moraxella catarrhalis
DD295553A5 (de) Impfstoff gegen die lyme-krankheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL